跳至主要内容
临床试验/EUCTR2006-000044-71-GB
EUCTR2006-000044-71-GB进行中(未招募)1 期

Randomised controlled trial of the effects of fish oil emulsion in total parenteral nutrition upon tumour vascularity in patients with hepatic colorectal metastases - OMEGA-3 FATTY ACIDS AND HEPATIC COLORECTAL METASTASES

niversity Hospitals of Leicester NHS Trust Research & Development Department0 个研究点目标入组 20 人开始时间: 2006年6月11日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Patients with hepatic colorectal metastases, in whom the disease is assessed as amenable to curative resection will be eligible for the study. The inclusion criteria will be:
  • ·Aged 18-80
  • ·Able to give informed written consent
  • ·Diagnosis of respectable hepatic colorectal metastases on radiological and laparoscopic appearances
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients will be excluded from this trial if they have:
  • ·Hypersensitivity to fish-, egg-, or soy protein, or to any of the active substances or constituents in the lipid emulsion
  • ·Hyperlipidaemia
  • ·Severe blood coagulation disorders
  • ·Severe renal insufficiency (Creatinine >200)
  • ·Any general contra-indications to infusion therapy – pulmonary oedema, hyperhydration, decompensated cardiac insufficiency
  • ·Any unstable medical conditions – uncontrolled diabetes mellitus, acute myocardial infarction, stroke, embolic disease, metabolic acidosis, sepsis, pancreatitis
  • ·Patients undergoing conventional neo-adjuvant chemotherapy
  • . Cardiac pacemaker or any other ferromagnetic implant not authorised for use in MRI

研究者

发起方
niversity Hospitals of Leicester NHS Trust Research & Development Department

相似试验